ArticleThe journal of allergy and clinical immunology. Global2026
Real-world efficacy and safety of omalizumab in chronic spontaneous urticaria: Insights from the Middle East.
Shuayb Elkhalifa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.